AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Donor SelectionTissue DonorsHistocompatibilityHistocompatibility TestingBone Marrow TransplantationBone MarrowGraft vs Host DiseaseTransplantation, HomologousLiving DonorsBlood DonorsHematopoietic Stem Cell TransplantationBone Marrow CellsSelection, GeneticTissue and Organ ProcurementRegistriesLiver TransplantationHLA AntigensGraft SurvivalTreatment OutcomeBone Marrow DiseasesBone Marrow ExaminationUnited StatesHematopoietic Stem CellsNational Institutes of Health (U.S.)Bone Marrow NeoplasmsTime FactorsBone Marrow PurgingNational Health ProgramsHematopoiesisMice, Inbred C57BLRetrospective StudiesColony-Forming Units AssayMolecular Sequence DataCell DifferentiationOrganizations, NonprofitBlood BanksCord Blood Stem Cell Transplantation
NMDPTransplantationPBSCHaploidenticalDonationPeripheral blood stem cellsStem cellBone marrow transplantsUmbilical cord bloodPatientsTransplantsDisordersDisease Control and PreventionCytomegalovirusSibling or unrelated donorRecipientSuitable donors2016Major DonorAmerican AssocAllogeneicEligibilityRegistryLymphatic systemHematopoietic cellsOncologyMalignanciesApheresisPBSCsOrganRecipientsAdultProgenitor cellsTransplant outcomesClosely matchedInfectionsTissueBlood transfusion servicesDiagnosisTissuesInfectious diseasesVolunteerEvaluationPotential2017
NMDP14
  • In this summary, the National Marrow Donor Program (NMDP) and the Center for International Blood and Marrow Transplant Research, jointly with the NMDP Histocompatibility Advisory Group, provide evidence-based guidelines for optimal selection of unrelated donors and cord blood units. (feministlawprofessors.com)
  • The National Marrow Donor Program (NMDP) is a nonprofit organization founded in 1986 and based in Minneapolis, Minnesota, that operates the Be The Match Registry of volunteer hematopoietic cell donors and umbilical cord blood units in the United States. (wikipedia.org)
  • Hematopoietic cells from NMDP donors or cord blood units are used to transplant patients with a variety of blood, bone marrow or immune system disorders. (wikipedia.org)
  • The NMDP coordinates the collection of hematopoietic ("blood-forming") cells that are used to perform what used to be called bone marrow transplants, but are now more properly called hematopoietic cell transplants. (wikipedia.org)
  • These organizations (mostly hospitals and blood banks) have established relationships with the NMDP and work together to arrange the collection and transfer of donated bone marrow or PBSCs, or the transfer of previously collected cord blood. (wikipedia.org)
  • When an adult volunteer donor (marrow or PBSC) registers with the NMDP, their HLA and contact information is sent to the NMDP, which stores it in their computers. (wikipedia.org)
  • Physicians look for donor material on behalf of a patient by submitting the patient's HLA tissue type to the NMDP, which then searches its computerized database for matching donor (marrow or PBSC) or cord blood units. (wikipedia.org)
  • If the NMDP finds a match with an adult donor, they notify the donor. (wikipedia.org)
  • After educating the potential donor about the donation process, the NMDP asks them to donate. (wikipedia.org)
  • If the potential donor meets all requirements, the NMDP collects their bone marrow or peripheral blood stem cells and sends them by courier to the patient. (wikipedia.org)
  • The NMDP cooperates with World Marrow Donor Association (WMDA), an organization that coordinates communications among the world's registries. (wikipedia.org)
  • The National Marrow Donor Program (NMDP), founded in 1986, and the World Marrow Donor Association (WMDA), founded in 1988, were established to (1) locate and secure appropriate unrelated-donor HSCT sources for patients by promoting volunteer donation of bone marrow and peripheral blood stem cells in the community and (2) promote ethical practices of sharing stem cell sources by need, rather than by geographic location of the donor. (medscape.com)
  • Contracted with the National Marrow Donor Program (NMDP)/Be the Match Network Transplant Center as a Marrow and Apheresis Collection Center. (stanfordhealthcare.org)
  • This center has been performing allogeneic transplants since 1985 and has been an NMDP/Be The Match transplant center since October 2001. (bethematch.org)
Transplantation23
  • Large registries of unrelated donors are needed because only about 30% of patients with diseases treatable with hematopoietic cell transplantation can find a fully HLA matched donor among their family members. (wikipedia.org)
  • Although previous recommendations for preventing transmission of human immunodeficiency virus (HIV) through transplantation of human tissue and organs have markedly reduced the risk for this type of transmission, a case of HIV transmission from a screened, antibody-negative donor to several recipients raised questions about the need for additional federal oversight of transplantation of organs and tissues. (cdc.gov)
  • Hematopoietic stem cell transplantation (HSCT) involves the intravenous infusion of hematopoietic stem cells in order to reestablish blood cell production in patients whose bone marrow or immune system is damaged or defective. (medscape.com)
  • Worldwide, approximately 90,000 first HSCTs-53% autologous and 47% allogeneic-are performed every year, according to the World Wide Network of Blood and Marrow Transplantation. (medscape.com)
  • Allogeneic haemopoietic stem cell transplantation offers a potentially curative treatment option for a wide range of life-threatening malignant and non-malignant disorders of the bone marrow and immune system in patients of all ages. (nih.gov)
  • We report UK consensus guidelines on the selection of umbilical cord blood units, the hierarchy of donor selection and the preferred conditioning regimens for umbilical cord blood transplantation, with a summary of rationale supporting these recommendations. (nih.gov)
  • Among the topics covered are age-related issues with regard to gene expression patterns in kidney transplant recipients and selection of donor-recipient combinations in liver transplantation. (tts.org)
  • The conference will bring together international and national faculties who will share their knowledge and expertise in the field of organ transplantation. (tts.org)
  • The incidence of severe adverse events (SAEs) and associated risk factors in hematopoietic cell transplantation donors needs to be clarified for related donors (relatives of the transplant recipient), whose criteria for donation are more lenient than for unrelated donors. (bvsalud.org)
  • Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia. (mcw.edu)
  • Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. (mcw.edu)
  • Unrelated Donor Cord Blood Transplantation in Children: Lessons Learned Over 3 Decades. (mcw.edu)
  • Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. (mcw.edu)
  • EBA is a member of the Common Representation of Substance of Human Origin (CoRe SoHO), the consortium of professional scientific associations in the field of SoHO and that also includes the European Association of Tissue and Cell Banks (EATCB), the European Eye Bank Association (EEBA) and the European Society for Blood and Marrow Transplantation (EBMT). (europeanbloodalliance.eu)
  • 2003). After the early success of transplantation of cord blood from related donors, cord blood banks were established to provide rapidly accessible, human leukocyte antigen (HLA)-typed units predominantly for transplantation of HPCs from unrelated donors. (nationalacademies.org)
  • Blood and Marrow Transplant Research [CIBMTR] in 2004), the European Research Project on Cord Blood Transplantation (Eurocord) in 1993, and the Japanese Cord Blood Banking Network in 1996-expedited the clinical evaluation of the efficacy and safety of transplantation of cord blood from unrelated donors. (nationalacademies.org)
  • Be The Match® is a global leader in bone marrow transplantation. (bethematch.org)
  • 99% of transplantation centers in Japan. (apbmt.org)
  • The Japanese Society of Hematopoietic Cell Transplantation (JSHCT) has been conducting a nationwide survey on HCT since 1993, in which HCTs performed at participating centers are registered with the JSHCT every year. (apbmt.org)
  • 300 transplantation centers nationwide, with a penetration rate exceeding 99% 1 . (apbmt.org)
  • Various factors including age, sex, performance status (PS), disease status, cytogenetic risk, donor type, graft source, sex mismatch between the donor and the recipient, and year of transplantation were all shown to impact OS 2 . (apbmt.org)
  • Bone Marrow Transplantation, 2013. (nih.gov)
  • SCID is considered a pediatric emergency because survival depends on expeditious stem cell reconstitution, usually by bone marrow transplantation (BMT). (medscape.com)
PBSC6
  • The transplant physician evaluating the patient considers a number of clinical factors to decide whether to use an adult donor's marrow or PBSC, or cord blood for a particular patient. (wikipedia.org)
  • This is a single arm pilot study using TCR alpha/beta+ T cell-depleted peripheral blood stem cells (PBSC) from closely matched unrelated donors or partially matched/haploidentical related donors for hematopoietic stem cell transplant (HSCT) in patients with acquired and inherited bone marrow failure (BMF) syndromes. (sparkcures.com)
  • Data from related donors registered in the Japanese national data registry database between 2005 and 2021 were evaluated to determine the association of short-term SAE incidence with donor characteristics at registration.Fourteen of 4339 bone marrow (BM) donors (0.32%) and 54 of 10,684 peripheral blood stem cell (PBSC) donors (0.51%) experienced confirmed SAEs during the short donation period. (bvsalud.org)
  • Past medical history was a common risk factor for SAEs in both BM and PBSC donors. (bvsalud.org)
  • Age of 60 years or older and female sex were identified as risk factors for SAEs in PBSC donors. (bvsalud.org)
  • Female sex was also a risk factor for poor mobilization, which resulted in discontinuation of PBSC collection.Although donors should be selected carefully, a certain level of safety is ensured for related donors in Japan. (bvsalud.org)
Haploidentical2
  • With rapidly emerging advances in the use of alternative donors, such as mismatched unrelated, cord blood and haploidentical donors, it is now possible to find a potential donor for almost all patients in whom an allograft is indicated. (nih.gov)
  • Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type. (mcw.edu)
Donation7
  • and recall of stored tissues from donors found after donation to have been infected. (cdc.gov)
  • A 1991 investigation determined that several recipients had been infected with HIV by an organ/tissue donor who had tested negative for HIV antibody at the time of donation (4). (cdc.gov)
  • The personnel collecting tissue (doctors and nurses authorised to perform the duty) are provided with personal and health-related data of the donor for identification and donation eligibility purposes. (veripalvelu.fi)
  • Below, you will find answers to frequently asked questions about DKMS, bone marrow and blood stem cell donation, transplants, and fundraising efforts. (dkms.org)
  • Learn how marrow donation works, the steps of a patient transplant, steps of donation, and factors that can impact the likelihood of finding a match. (bethematch.org)
  • University of Illinois-Champaign, Blood or Blood Platelet Donor Leave PolicyBlood or blood platelet donor leave is provided for under State of Illinois Act (820 ILCS 149/1) Employee Blood Donation Leave Act . (siue.edu)
  • Blood Donation Centers serve as the sole provider of blood for 15 area hospitals. (communityconnectionssjc.org)
Peripheral blood stem cells1
  • The number of related HCTs has remained stable, while the use of peripheral blood stem cells (PBSCs) has now largely replaced that of bone marrow (BM). (apbmt.org)
Stem cell5
  • We also handle cell collection from donors or from cord blood to prepare for stem cell transplants and cell therapies. (stanfordhealthcare.org)
  • Exa-cel is now approved for use in eligible patients aged 12 and over with sickle cell disease who have recurrent vaso-occlusive (VOC) crises, or TDT for whom a human leukocyte antigen-matched related hematopoietic stem cell donor is not available. (hospitalpharmacyeurope.com)
  • The contact details of the donor are disclosed from the stem cell register with the donor's consent. (veripalvelu.fi)
  • Called a savior sibling, such an embryo deemed free of disease is implanted with the intent to be born to serve as a stem cell or organ donor to the diseased sibling, explained Susan Wolf, JD, McKnight Presidential Professor of law, medicine and public policy at the University of Minnesota in Minneapolis. (aacc.org)
  • We have several programs and features unique to our center, including the Adolescent and Young Adult Program (AYA), Transplant Optimization Program (TOP) for our older adult patients, and an outpatient stem cell transplant unit which allows us to offer outpatient transplant to eligible patients. (bethematch.org)
Bone marrow transplants1
Umbilical cord blood1
  • Therefore, for any specific patient, the transplant physician may be faced with a myriad of potential choices, including decisions concerning which donor to prioritize where there is more than one, the optimal selection of specific umbilical cord blood units and which conditioning and graft-versus-host disease prophylactic schedule to use. (nih.gov)
Patients17
  • Generous blood donors are the only source of blood for patients in need of a blood transfusion. (feministlawprofessors.com)
  • Patients needing a hematopoietic cell transplant but who lack a suitably matched donor in their family can search the Be The Match Registry for a matched unrelated donor or cord blood unit. (wikipedia.org)
  • He has also served as the Chairman of the Board for Kids Beating Cancer, Inc., a multiple award-winning local charity that assists families touched by childhood cancer through the recruitment, DNA testing and matching of potential bone marrow donors to patients whose best hope for a cure is a bone marrow transplant. (bestlawyers.com)
  • I am very grateful to my colleagues both at the Trust and the other centres involved in the trials and patient selection for their hard work, but most of all to the patients for their willingness to explore innovative therapies and their daily inspiration. (hospitalpharmacyeurope.com)
  • The manufacturer Vertex Pharmaceuticals is working closely with the National Institute for Health and Care Excellence to secure access for patients as soon as possible. (hospitalpharmacyeurope.com)
  • Patients who have been treated with cell therapy products manufactured by the Advanced Cell Therapy Center: name, personal identity code, age, weight, diagnosis, treatment time, cell therapy product dosage information, potential adverse events. (veripalvelu.fi)
  • Current surveillance strategies for patients with SDS and other leukemia predisposition syndromes rely on monitoring hematologic status by serial peripheral blood counts to identify worsening cytopenias and bone marrow examinations to identify morphologic changes or development of clonal chromosomal abnormalities 11 . (nature.com)
  • Cansearch is produced by the National Coalition for Cancer Survivorship (NCCS) to provide survivors and patients with a step-by-step guide to the many cancer resources found on the Web. (oncologyindia.org)
  • This organization conducts national and regional conferences, publishes printed materials for patients and family members, provides access to a national network of patient support groups, and assists in answering patient inquiries. (oncologyindia.org)
  • Every day, we help save lives by adding more potential donors to the bone marrow registry and connecting patients in need of a transplant with matching donors who can make it happen. (dkms.org)
  • Globally, we've registered more than 9 million potential donors, and more than 70,000 of these have gone on to donate to patients. (dkms.org)
  • The study included clinical data of 18 adult patients with primary HLH treated in our center from June 2010 to January 2017. (biomedcentral.com)
  • EBA also cooperates regularly with a wide range of partner organisations representing donors, patients, health professional groups and many other sectoral and scientific communities. (europeanbloodalliance.eu)
  • We also perform haplo and mismatched unrelated donor transplant or cord transplant for patients who do not have a fully matched donor. (bethematch.org)
  • We also have our Center for International Patients which provides personalized and coordinated medical care to patients coming from abroad. (bethematch.org)
  • For this center, we have survival information for 24 patients. (bethematch.org)
  • 15% of patients with SCD have an HLA-matched sibling donor. (nih.gov)
Transplants3
  • Join us to hear Dr. Koen van Besien from Seidman Cancer Center at University Hospital (Cleveland, Ohio) discuss innovations in cord blood transplants, including haplo-cord transplants for HIV, leukemia and more. (savethecordfoundation.org)
  • With more than 6,000 transplants of cord blood from related and unrelated donors performed thus far, cord blood has emerged as an acceptable, alternative source of HPCs that has some advantages over adult sources of HPCs and the availability of which represents an important development in the field. (nationalacademies.org)
  • Our research team is at the forefront of improvements in conditioning regimens and alternative donor transplants including cord and mismatched donor transplant. (bethematch.org)
Disorders3
  • Donor choice may be further complicated by other important factors, such as urgency of transplant, the presence of alloantibodies, the disease status (homozygosity or heterozygosity) of sibling donors affected by inherited disorders and the cytomegalovirus serostatus of patient and donor. (nih.gov)
  • a broad range of disorders for which transplantion of HPCs from an adult donor is also successful, including hematological malignancies, solid tumors, constitutional and acquired bone marrow failure syndromes, hemoglobinopathies, congenital immune deficiencies, and inherited disorders of metabolism (Gluckman et al. (nationalacademies.org)
  • Blood and blood products are essential in the treatment of blood and bone marrow disorders, as well as immune deficiency conditions. (who.int)
Disease Control and Prevention2
  • The Centers for Disease Control and Prevention (CDC) report that more than 75% of the recently emerging infectious diseases affecting humans are of animal origin. (clpmag.com)
  • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
Cytomegalovirus3
  • Why is Cytomegalovirus not routinely tested among blood donors in several countries like Nigeria? (researchgate.net)
  • As stated in the journal article, Cytomegalovirus donor seroprevalence ranges from 40-100% across the globe. (researchgate.net)
  • With this, why is transfusion transmissible infection (TTI) such as Cytomegalovirus not routinely tested among blood donors in several countries like Nigeria? (researchgate.net)
Sibling or unrelated donor1
  • Cells for HSCT may be obtained from the patient himself or herself (autologous transplant) or from another person, such as a sibling or unrelated donor (allogeneic transplant) or an identical twin (syngeneic transplant). (medscape.com)
Recipient1
  • Data processing is based on cell therapy products manufacturing and on operating permits granted for tissue collection (national ATMP manufacturing permission, tissue establishment operating permit) as well as on the statutory obligation to retain the personal data of the donor and the recipient of the cell therapy product in order to ensure statutory traceability. (veripalvelu.fi)
Suitable donors2
  • An important barrier to HSCT has been the inability to secure a suitable donors. (medscape.com)
  • Carrier testing of family members through gene sequencing, cytotoxicity analysis and protein measurements can result not only in the identification of yet healthy homozygous carriers but also aid the selection of suitable donors in the family. (biomedcentral.com)
20162
  • The regional strategic framework for blood safety and availability (2016-2025) is intended to guide countries in developing and strengthening national blood systems to ensure the continuity, sufficiency, sustainability and security of national supplies of safe and efficacious blood and blood components to meet national needs. (who.int)
  • The regional strategic framework for blood safety and availability (2016-2025) is intended to address the gaps in national blood transfusion services in the Region and improve the safety and availability of blood and blood products. (who.int)
Major Donor1
  • A leading fundraiser specialising in major donor campaigns. (thejc.com)
American Assoc1
  • This report describes a cognitive interviewing study conducted by the Questionnaire Design Research Laboratory (QDRL) at the National Center for Health Statistics (NCHS) to examine the performance of the long form version of the American Association of Blood Banks (AABB) Uniform Blood Donor History Questionnaire (UBDHQ). (cdc.gov)
Allogeneic1
  • Understanding donor HLA characteristics and their impact on the final therapy can ultimately improve allogeneic cell therapy outcomes. (bethematchbiotherapies.com)
Eligibility4
  • Officially Recognized by the FDA in Guidance use of the aDHQ is limited to qualified frequent donors with no changes to their eligibility. (feministlawprofessors.com)
  • Data is used to assess the eligibility to donate and to ensure the safety of both the donor and the patient as well as to fulfil statutory obligations. (veripalvelu.fi)
  • Evaluation of donor eligibility and storing the tissue are not covered by the tissue establishment authorisation granted to the Blood Service. (veripalvelu.fi)
  • Implement strict donor eligibility criteria, including assessing risk factors for TTDs such as sexual behavior, travel history, and medical history. (researchgate.net)
Registry3
  • The Be The Match Registry is one of many registries of unrelated donors and cord blood units in the world. (wikipedia.org)
  • Everyone who registered with Delete Blood Cancer remains on file with DKMS and on the national registry. (dkms.org)
  • ETHICS AND DISSEMINATION: This research was approved by the Central Review Board at National Hospital Organization Nagoya Medical Center (Nagoya, Japan) on 21 January 2022 and was registered at the Japan Registry of Clinical Trials (jRCT) on 3 March 2022. (bvsalud.org)
Lymphatic system1
  • Leukemias begin in the bone marrow, whereas lymphomas start in the lymphatic system. (dkms.org)
Hematopoietic cells1
  • PBSCs are collected from the donor's blood after five or six days of taking a drug that causes hematopoietic cells in the bone marrow to move into the circulating blood. (wikipedia.org)
Oncology1
  • Lymphography: This lymphography domain was obtained from the University Medical Centre, Institute of Oncology, Ljubljana, Yugoslavia. (webstek.org)
Malignancies1
  • To understand the mechanisms that mediate germline genetic leukemia predisposition, we studied the inherited ribosomopathy Shwachman-Diamond syndrome (SDS), a bone marrow failure disorder with high risk of myeloid malignancies at an early age. (nature.com)
Apheresis1
  • As a cell and gene therapy developer, your cell collection protocol requirements and specifications will impact your apheresis center network selection strategy and your ability to efficiently scale your processes. (bethematchbiotherapies.com)
PBSCs1
  • Bone marrow and PBSCs come from living adult donors. (wikipedia.org)
Organ1
Recipients1
  • Avoiding and monitoring transfusion-transmissible diseases (TTDs) is crucial to ensure the safety of blood transfusions and protect both donors and recipients. (researchgate.net)
Adult1
  • Caregiving families can also find support services through this program, as well as referrals to other programs and services available for older and disabled adults.Adult Day Services helps fill the gap between senior cen. (communityconnectionssjc.org)
Progenitor cells1
Transplant outcomes1
Closely matched1
  • To date, a bone marrow transplant - which must come from a closely matched donor and carries a risk of rejection - has been the only permanent treatment option. (hospitalpharmacyeurope.com)
Infections1
  • Blood donor tests may not be available for some infections that are found only in certain countries. (feministlawprofessors.com)
Tissue4
  • Donor of tissues for cell therapy product manufacturing: name, personal identity code, address, phone number, e-mail address, sex, laboratory test results (such as virus screening tests), tissue type and blood group. (veripalvelu.fi)
  • Regarding the product LY-MSC: Together with announcing their interest in donating tissue, donors of bone marrow tissue provide basic information concerning themselves and give their consent for contacting them in order to manufacture cell therapy products. (veripalvelu.fi)
  • An exception to identification codes and batch labels of samples and products: with cell therapy products manufactured from the patient's own tissue and with relative donations, we have a statutory obligation to label the products also with the personal identification codes of the patient and the donor. (veripalvelu.fi)
  • If the tissue donor is diagnosed with some disease to be reported under the Communicable Diseases Act, data will be disclosed to the National Infectious Diseases Register as required by the above-mentioned act. (veripalvelu.fi)
Blood transfusion services3
  • Ensure that regulatory agencies and blood transfusion services have clear guidelines and standards for donor screening, testing, and quality control. (researchgate.net)
  • WHO undertook a comprehensive situation analysis of national blood transfusion services, in the Region, using data collected from 18 countries which was verified by the directors of the national blood transfusion services. (who.int)
  • In 1987, at its 34th session the Regional Committee endorsed resolution EM/RC34/R.9 on the development of national blood transfusion services in the countries of the Eastern Mediterranean Region. (who.int)
Diagnosis3
  • If a diagnosis of the disease is made by prenatal testing, the family can initiate the search for a matched bone marrow sample even before the child is born. (catholiclane.com)
  • This is a service of the University of Wisconsin Comprehensive Cancer Center, providing accurate and up-to-date information from reliable sources on breast cancer prevention, detection, diagnosis, stage, and treatment. (oncologyindia.org)
  • Family surveys and immunological markers were important for the HLH diagnosis and the selection of an appropriate donor. (biomedcentral.com)
Tissues1
  • In 1985, when tests for HIV antibody became available, screening prospective donors of blood, organs, and other tissues also began (2,3). (cdc.gov)
Infectious diseases1
  • If the potential donor wishes to proceed, they receive a medical exam, which includes testing the blood for infectious diseases. (wikipedia.org)
Volunteer1
  • Because the odds that two random individuals are HLA matched exceeds one in 20,000, a registry's success depends on a large number of volunteer donors. (wikipedia.org)
Evaluation1
Potential4
  • Conduct confidential interviews with potential donors to identify high-risk behaviors. (researchgate.net)
  • Bone marrow stem cells, including the pluripotent hematopoietic stem cells (HSCs) and bone mesenchymal stem cells (BMSCs), are being considered as potential targets for cell and gene therapy-based approaches against a variety of different diseases. (hindawi.com)
  • The questionnaire is used by most U.S. blood centers to screen potential blood donors. (cdc.gov)
  • Study objectives were to assess question interpretation, understand potential donors' processes for formulating a response, identify question design problems that could increase inaccurate reports, and compare interpretations between those in different geographic regions. (cdc.gov)
20171
  • Dr. Bateman's work has been recognized by a number of awards including his selection in 2017 by the Society for Obstetric Anesthesia and Perinatology as the Gerard Ostheimer lecturer and in 2018 by the American Society of Anesthesiologists as the James E. Cottrell Presidential Scholar Awardee, which is given to one clinical-scientist each year within 10 years of initial faculty appointment for accomplishment in research. (stanford.edu)